Brief: Diasorin Receives Approval For HDV Laboratory Test In The U.S.
29/01/2026 06:08
Jan 29 (Reuters) - DiaSorin SpA DIAS.MI: DIASORIN RECEIVES DE NOVO APPROVAL IN THE UNITED STATES FOR THE FIRST FULLY AUTOMATED LABORATORY TEST FOR HEPATITIS DELTA VIRUS (HDV) ON THE LIAISON XL SYSTEM FULLY AUTOMATED HDV IMMUNOASSAY TEST ON DIASORIN LIAISON XL TO BE AVAILABLE IN THE U.S. STARTING FEB 2026 Further company coverage: DIAS.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21